|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Denali Therapeutics (NASDAQ: DNLI) through any online brokerage.
The latest price target for Denali Therapeutics (NASDAQ: DNLI) was reported by UBS on May 18, 2021. The analyst firm set a price target for 70.00 expecting DNLI to fall to within 12 months (a possible -6.67% downside). 9 analyst firms have reported ratings in the last year.
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $75 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Denali Therapeutics.
There is no upcoming split for Denali Therapeutics.
Denali Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.